Diagnostic kit for rapid test kit Fungus Medium Kit
USD $1 - $10 /Box
Min.Order:500 Boxes
Hunan Lituo Biotechnology Co., Ltd.
Helicobacter Pylori (HP)Test Card/Rapid Helicobacter Pylori Test Card
Rapid Helicobacter Pylori Test Card/Rapid HP (Helicobacter Pylori ) Test Kit
Helicobacter Pylori (HP)Test Card/Rapid Helicobacter Pylori Test Card with ISO Approved
RUT/Helicobacter Pylori (HP)Test /Rapid Helicobacter Pylori Rapid Test (Urease)
Fungus Culture and Isolation Kit
Features:
1. High sensitivity, accuracy and specificity.
2. Fungus interpretation and susceptibility are completed in the same test board and one time.
3. Distinct coloration and fast testing.
Significance:
The incidence of fungus infection has been rising constantly globally. The incidence and case fatality rate resulted from fungus infection show an increasing tendency. The case fatality rate of monilial septicemia reaches up to 45% - 76% without treatment. The mortality rate is up to 70% - 90% for peoples who accept bone marrow transplantation. The deep fungal infection is very pernicious. Effective and rapid identification plays an important role in the fungus' diagnosis and treatment.
Diagnosis principle:
Different saccharides and enzyme catalysis substrates are coated in holes of testing board to take advantage of fungus biochemical reaction and specificity enzyme catalysis. The fungi can be interpreted according the difference of saccharide assimilation test and enzyme catalysis.
Seven antibiotics clinically used to treat fungi at present are coated in the holes of the susceptibility area according to MIC (Minimum Inhibitory Concentration) recommended by NCCLS (National Committee for Clinical Laboratory Standards). The susceptibility levels (susceptible, intermediate and resistant) are judged by the situation in which antibiotics inhibits the growth of fungi.
Initiated from 2000, Lituo Biotech is a national hi-tech enterprise specializing in R&D, production and marketing of high-quality in-vitro diagnostic reagents and clinical laboratory instruments. Lituo now possesses three subsidiaries: Zhuhai Lituo Development Co., Ltd., Hunan Lituo Biotechnology Co., Ltd and Changsha Lanxin Biotechnology Co., Ltd.
Lituo Biotech has strong R&D capability and leads the industry tendency. Lituo developed nearly 30 products including diagnostic reagents and instruments benefiting from its high calibre R&D teams, high investment of scientific research and efficient R&D management system.